Phase II study of whole brain radiotherapy with or without erlotinib in patients with multiple brain metastases from lung adenocarcinoma

Overview of attention for article published in Drug Design, Development and Therapy, October 2013

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (66th percentile)
Above-average Attention Score compared to outputs of the same age and source (61st percentile)

Mentioned by

policy: 1 policy source

twitter: 1 X user

Citations

dimensions_citation: 79 Dimensions

Readers on

mendeley: 57 Mendeley

Summary Policy documents X Dimensions citations

So far, Altmetric has seen 1 X post from an account with 34 followers.

Phase II study of whole brain radiotherapy with or without erlotinib in patients with multiple brain metastase... http://t.co/2nvzaYVCCa

Reply Repost Favourite